All stock lists
Vontier Corp (New York Stock Exchange:VNT)
US · Delayed Price · Currency is USD
Technology · Hardware, Equipment & Parts
34.49+0.14 (+0.39%)
Insider Score
––Not scored
VNT Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
VNT analyst forecast
VNT analyst consensus
Moderate Buy2 ratings
Buy 2 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
VNT 12-month price target
No published price targets in the last 12 months.
Best analysts covering VNT
- Barclays100%success rate · 13 calls
- B of A Securities100%success rate · 1 call
- Citigroup60%success rate · 10 calls
- Evercore ISI Group33%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
VNT analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-08-11 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-08-07 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-07-13 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-05-08 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-08 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-05-08 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-01 |
| — | Baird | Neutral | — | — | Reiterated | 2026-03-30 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-02-23 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-02-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-02-13 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2025-11-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-11-03 |
| — | Baird | Neutral | — | — | Reiterated | 2025-11-03 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-10-31 |
| — | UBS | Buy | — | — | Reiterated | 2025-08-05 |
| — | Argus Research | Buy | — | — | Upgraded | 2025-08-05 |
| — | Baird | Neutral | — | — | Reiterated | 2025-08-04 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-07-14 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-05-19 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-05-05 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-04-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-03-26 |
| — | Baird | Neutral | — | — | Reiterated | 2025-02-18 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-02-14 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-01-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-01-08 |
| — | Wolfe Research | Outperform | — | — | Upgraded | 2024-12-12 |
| — | Citigroup | Buy | — | — | Reiterated | 2024-12-09 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-11-05 |
| — | Argus Research | Hold | — | — | Downgraded | 2024-08-20 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2024-08-19 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-08-05 |
| — | Baird | Neutral | — | — | Reiterated | 2024-08-02 |
| — | Citigroup | Buy | — | — | Reiterated | 2024-04-08 |
| — | Argus Research | Buy | — | — | Reiterated | 2024-03-18 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2024-02-20 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2024-02-20 |
| — | Citigroup | Buy | — | — | Reiterated | 2024-02-16 |
| — | UBS | Buy | — | — | Reiterated | 2024-02-16 |
| — | B of A Securities | Buy | — | — | Upgraded | 2024-01-11 |
| — | Citigroup | Buy | — | — | Reiterated | 2023-12-11 |
| — | Barclays | Overweight | — | — | Reiterated | 2023-08-07 |
| — | Barclays | Overweight | — | — | Reiterated | 2023-07-10 |
| — | Citigroup | Buy | — | — | Reiterated | 2023-06-12 |
| — | Argus Research | Buy | — | — | Reiterated | 2023-05-19 |
| — | Barclays | Overweight | — | — | Reiterated | 2023-05-10 |
| — | Citigroup | Buy | — | — | Reiterated | 2023-05-05 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2023-03-28 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2023-03-27 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2023-03-17 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2023-02-21 |
| — | Citigroup | Buy | — | — | Reiterated | 2023-02-17 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2022-12-13 |
| — | B of A Securities | Neutral | — | — | Downgraded | 2022-12-12 |
| — | Wolfe Research | Peer Perform | — | — | Downgraded | 2022-12-01 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2022-11-04 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2022-11-04 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2022-10-11 |
| — | Barclays | Overweight | — | — | Reiterated | 2022-10-03 |
VNT earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-12 | 0.85 | 0.86 | $764.7M | $808.5M |
| 2026-05-07 | 0.82 | 0.80 | $737.2M | $750.6M |
| 2026-08-06 | 0.81 | 0.89 | $747.1M | $756.7M |
| 2026-11-05 | 0.84 | 0.00 | $728.0M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.